These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7577996)

  • 41. Disulfide locked variants of factor VIIa with a restricted beta-strand conformation have enhanced enzymatic activity.
    Maun HR; Eigenbrot C; Raab H; Arnott D; Phu L; Bullens S; Lazarus RA
    Protein Sci; 2005 May; 14(5):1171-80. PubMed ID: 15840825
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Blood clotting reactions on nanoscale phospholipid bilayers.
    Morrissey JH; Pureza V; Davis-Harrison RL; Sligar SG; Ohkubo YZ; Tajkhorshid E
    Thromb Res; 2008; 122 Suppl 1(Suppl 1):S23-6. PubMed ID: 18691494
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Importance of phosphatidylethanolamine for the interaction of apocytochrome c with model membranes containing phosphatidylserine.
    Ahn T; Oh DB; Lee BC; Yun CH
    Biochemistry; 2000 Aug; 39(33):10147-53. PubMed ID: 10956003
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of phosphatidylserine on membrane incorporation and surface protection properties of exchangeable poly(ethylene glycol)-conjugated lipids.
    Chiu GN; Bally MB; Mayer LD
    Biochim Biophys Acta; 2002 Feb; 1560(1-2):37-50. PubMed ID: 11958774
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tissue factor and its extracellular soluble domain: the relationship between intermolecular association with factor VIIa and enzymatic activity of the complex.
    Waxman E; Ross JB; Laue TM; Guha A; Thiruvikraman SV; Lin TC; Konigsberg WH; Nemerson Y
    Biochemistry; 1992 Apr; 31(16):3998-4003. PubMed ID: 1567850
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intramitochondrial distribution and transport of phosphatidylserine and its decarboxylation product, phosphatidylethanolamine. Application of pyrene-labeled species.
    Jasińska R; Zborowski J; Somerharju P
    Biochim Biophys Acta; 1993 Oct; 1152(1):161-70. PubMed ID: 8399295
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cellular immune and cytokine pathways resulting in tissue factor expression and relevance to septic shock.
    Edgington TS; Mackman N; Fan ST; Ruf W
    Nouv Rev Fr Hematol (1978); 1992; 34 Suppl():S15-27. PubMed ID: 1364116
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Formation of tissue factor-factor VIIa-factor Xa complex prevents apoptosis in human breast cancer cells.
    Jiang X; Guo YL; Bromberg ME
    Thromb Haemost; 2006 Aug; 96(2):196-201. PubMed ID: 16894464
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Different modeling approaches in the simulation of extrinsic coagulation factor X activation: Limitations and areas of applicability.
    Kovalenko TA; Panteleev MA; Sveshnikova AN
    Int J Numer Method Biomed Eng; 2023 Nov; 39(11):e3689. PubMed ID: 36802118
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phosphatidylethanolamine derived from phosphatidylserine is deacylated and reacylated in rat hepatocytes.
    Samborski RW; Vance DE
    Biochim Biophys Acta; 1993 Mar; 1167(1):15-21. PubMed ID: 8461328
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tissue factor de-encryption, thrombus formation, and thiol-disulfide exchange.
    Chen VM
    Semin Thromb Hemost; 2013 Feb; 39(1):40-7. PubMed ID: 23325480
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phospholipid interactions affect substrate hydrolysis by bovine brain phospholipase A1.
    Pete MJ; Exton JH
    Biochim Biophys Acta; 1995 Jun; 1256(3):367-73. PubMed ID: 7786901
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The epidermal growth factor receptor (EGFR) and proline rich tyrosine kinase 2 (PYK2) are involved in tissue factor dependent factor VIIa signalling in HaCaT cells.
    Wiiger MT; Prydz H
    Thromb Haemost; 2004 Jul; 92(1):13-22. PubMed ID: 15213840
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of the factor X activation peptide: a deletion mutagenesis approach.
    Rudolph AE; Mullane MP; Porche-Sorbet R; Daust HA; Miletich JP
    Thromb Haemost; 2002 Nov; 88(5):756-62. PubMed ID: 12428090
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cells and the activation of factor VII.
    Rao LV; Rapaport SI
    Haemostasis; 1996; 26 Suppl 1():1-5. PubMed ID: 8904164
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lipid composition of subcellular particles from sheep platelets. Location of phosphatidylethanolamine and phosphatidylserine in plasma membranes and platelet liposomes.
    Sánchez-Yagüe J; Llanillo M
    Biochim Biophys Acta; 1986 Apr; 856(2):193-201. PubMed ID: 3955038
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of phosphatidylethanolamine in assembly and function of the factor IXa-factor VIIIa complex on membrane surfaces.
    Falls LA; Furie B; Furie BC
    Biochemistry; 2000 Oct; 39(43):13216-22. PubMed ID: 11052674
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tissue factor alters the pK(a) values of catalytically important factor VIIa residues.
    Neuenschwander PF; Vernon JT; Morrissey JH
    Biochemistry; 2002 Mar; 41(10):3364-71. PubMed ID: 11876644
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Large enhancement of functional activity of active site-inhibited factor VIIa due to protein dimerization: insights into mechanism of assembly/disassembly from tissue factor.
    Stone MD; Harvey SB; Martinez MB; Bach RR; Nelsestuen GL
    Biochemistry; 2005 Apr; 44(16):6321-30. PubMed ID: 15835921
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A frequent human coagulation Factor VII mutation (A294V, c152) in loop 140s affects the interaction with activators, tissue factor and substrates.
    Toso R; Pinotti M; High KA; Pollak ES; Bernardi F
    Biochem J; 2002 Apr; 363(Pt 2):411-6. PubMed ID: 11931672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.